| Gene symbol | MAGEA1 | Synonyms | CT1.1, MAGE1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | MAGE family member A1 | ||||
| GTO ID | GTC1864 |
| Trial ID | NCT03441100 |
| Disease | Solid Tumor |
| Altered gene | MAGE-A1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | IMA202 |
| HLA | HLA phenotype positive |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase 1 Study Evaluating Genetically Modified Autologous T Cells Expressing a T-cell Receptor Recognizing a Cancer/Germline Antigen in Patients With Recurrent and/or Refractory Solid Tumors(ACTengine IMA202-101) |
| Year | 2018 |
| Country | United States|Germany |
| Company sponsor | Immatics US, Inc. |
| Other ID(s) | IMA202-101 |
| Cohort 1 | |||||||||
|
|||||||||